Merck Awarded Summary Judgment in Wis. Federal Singulair Action



DOCUMENTS
  • Order


GREEN BAY, Wis. — A Wisconsin federal judge has awarded Merck & Company Inc. summary judgment in a lawsuit targeting its asthma product Singulair, ruling the plaintiffs failed to show that the company had “newly acquired information” to support a label change via the FDA’s Changes Being Effected process.

In an Aug. 31 order, Judge William C. Griesbach of the U.S. District Court for the Eastern District of Wisconsin found a 2011 article proffered by the plaintiffs did not “reveal risks of a different type or greater severity or frequency than previously included in submissions to” the FDA.

Stephanie Hammar’s …

FIRM NAMES
  • Mayer Graff & Wallace LLP
  • Reinhart Boerner Van Deuren
  • Venable LLP





UPCOMING CONFERENCES




HarrisMartin's MDL Conference: The Current Mass Tort Landscape - Best Management Practices & Updates on Key Litigation

September 28, 2022 - St. Louis, MO
Four Seasons Hotel, St. Louis

MORE DETAILS



HarrisMartin’s Webinar Series: Acetaminophen ASD/ADHD Product Liability Litigation

October 21, 2022

MORE DETAILS